Yue Hui Su
Direktor/Vorstandsmitglied bei MAKALOT INDUSTRIAL CO., LTD.
Aktive Positionen von Yue Hui Su
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MAKALOT INDUSTRIAL CO., LTD. | Direktor/Vorstandsmitglied | 21.02.2011 | - |
Independent Dir/Board Member | - | - | |
IN WIN DEVELOPMENT INC. | Direktor/Vorstandsmitglied | 01.07.2015 | - |
Independent Dir/Board Member | 01.07.2015 | - | |
ENNOCONN CORPORATION | Direktor/Vorstandsmitglied | - | - |
Independent Dir/Board Member | - | - | |
FORMOSA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 09.07.2021 | - |
Independent Dir/Board Member | 09.07.2021 | - | |
CECI Engineering Consultants, Inc. | Direktor/Vorstandsmitglied | - | - |
Soochow University /Taiwan/ | Corporate Officer/Principal | - | - |
Karriereverlauf von Yue Hui Su
Ehemalige bekannte Positionen von Yue Hui Su
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TWI PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | - | - |
Independent Dir/Board Member | - | - | |
Soochow University | Corporate Officer/Principal | - | - |
BANK OF KAOHSIUNG CO., LTD. | Direktor/Vorstandsmitglied | 20.06.2002 | - |
Ausbildung von Yue Hui Su
National Taiwan University | Doctorate Degree |
Statistik
International
Taiwan | 10 |
China | 2 |
Operativ
Director/Board Member | 7 |
Independent Dir/Board Member | 5 |
Corporate Officer/Principal | 2 |
Sektoral
Consumer Services | 4 |
Electronic Technology | 3 |
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
BANK OF KAOHSIUNG CO., LTD. | Finance |
MAKALOT INDUSTRIAL CO., LTD. | Consumer Non-Durables |
IN WIN DEVELOPMENT INC. | Electronic Technology |
ENNOCONN CORPORATION | Electronic Technology |
FORMOSA PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
CECI Engineering Consultants, Inc. | |
TWi Pharmaceuticals, Inc.
TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
- Börse
- Insiders
- Yue Hui Su
- Erfahrung